Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 866 entries
View as:

A Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03567616 Org: User:
Start: 10/18/18 End: 06/18/20 Due: 06/18/21

A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03026166 Org: User:
Start: 03/30/17 End: 07/03/19 Due: 07/03/20

A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06698926 Org: User:
Start: 11/11/24 End: 03/15/26 Due: 03/15/27

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion Alone or in Combination With Oral, IV, Subcutaneous Daratumumab; Lenalidomide; Dexamethasone; Carfilzomib

Phase: N/A Priority: Normal
NCT ID: NCT06892522 Org: User:
Start: 06/02/25 End: 03/31/36 Due: 03/31/37

Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1

Phase: N/A Priority: Normal
NCT ID: NCT02629172 Org: User:
Start: 01/05/16 End: 02/28/19 Due: 02/28/20

Real Life Evaluation of Rheumatoid Arthritis Patients in Israel Treated With HUMIRA

Phase: N/A Priority: Normal
NCT ID: NCT02322723 Org: User:
Start: 02/29/16 End: 02/29/20 Due: 02/28/21

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03345836 Org: User:
Start: 11/29/17 End: 08/11/21 Due: 08/11/22

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977

Phase: N/A Priority: Normal
NCT ID: NCT04862286 Org: User:
Start: 07/24/21 End: 02/05/29 Due: 02/05/30

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

Phase: N/A Priority: Normal
NCT ID: NCT03345823 Org: User:
Start: 03/21/18 End: 09/03/27 Due: 09/03/28

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy

Phase: N/A Priority: Normal
NCT ID: NCT05296447 Org: User:
Start: 04/04/22 End: 05/31/28 Due: 05/31/29

A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administrations With a Pre-Filled Syringe or an On-Body Injector in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT07007091 Org: User:
Start: 06/12/25 End: 12/31/25 Due: 12/31/26

A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, Illinois

Phase: N/A Priority: Normal
NCT ID: NCT04611230 Org: User:
Start: 11/05/20 End: 10/27/21 Due: 10/27/22

An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT06764693 Org: User:
Start: 01/31/25 End: 02/28/29 Due: 02/28/30

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

Phase: N/A Priority: Normal
NCT ID: NCT06084481 Org: User:
Start: 11/09/23 End: 07/31/26 Due: 07/31/27

Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT05785715 Org: User:
Start: 04/24/23 End: 12/31/25 Due: 12/31/26

A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02016482 Org: User:
Start: 01/31/14 End: 04/30/16 Due: 04/30/17

Real-World Experience Study of Elagolix For the Treatment of Endometriosis in Canada

Phase: N/A Priority: Normal
NCT ID: NCT04080856 Org: User:
Start: 12/04/19 End: 09/27/21 Due: 09/27/22

Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity

Phase: N/A Priority: Normal
NCT ID: NCT05956509 Org: User:
Start: 01/12/24 End: 06/02/24 Due: 06/02/25

Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01380704 Org: User:
Start: 06/30/11 End: 09/30/11 Due: 09/30/12

A Study on the Safety and Tolerability of Rovalpituzumab Tesirine in Japanese Patients With Advanced, Recurrent Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03086239 Org: User:
Start: 04/28/17 End: 08/20/18 Due: 08/20/19

Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03334487 Org: User:
Start: 03/15/18 End: 12/20/18 Due: 12/20/19

Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder

Phase: N/A Priority: Normal
NCT ID: NCT01192568 Org: User:
Start: 05/17/11 End: 10/24/23 Due: 10/24/24

Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial Spondyloarthritis

Phase: N/A Priority: Normal
NCT ID: NCT01808118 Org: User:
Start: 04/16/13 End: 04/14/17 Due: 04/14/18

A Study to Assess Disease Activity of Intravenously (IV) Infused Telisotuzumab Vedotin in Adult Participants With Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT05513703 Org: User:
Start: 11/21/22 End: 10/28/24 Due: 10/28/25

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection

Phase: N/A Priority: Normal
NCT ID: NCT02651194 Org: User:
Start: 12/31/15 End: 01/31/17 Due: 01/31/18